Debt-to-equity of THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. from 31 Mar 2012 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2024.
  • THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Debt-to-equity for the quarter ending 30 Sep 2024 was 156%, a 7.9% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2024 156% -13% -7.9% 30 Sep 2024
Q2 2024 158% -1% -0.64% 30 Jun 2024
Q1 2024 154% +7.5% +5.1% 31 Mar 2024
Q4 2023 168% +43% +34% 31 Dec 2023
Q3 2023 169% -8.2% -4.6% 30 Sep 2023
Q2 2023 159% -212% -57% 30 Jun 2023
Q1 2023 146% +1171% 31 Mar 2023
Q4 2022 125% +320% 31 Dec 2022
Q3 2022 177% +336% 30 Sep 2022
Q2 2022 371% +519% 30 Jun 2022
Q1 2022 -1024% -888% -649% 31 Mar 2022
Q4 2021 -195% -67% -53% 31 Dec 2021
Q3 2021 -159% -37% -30% 30 Sep 2021
Q2 2021 -148% 30 Jun 2021
Q1 2021 -137% 31 Mar 2021
Q4 2020 -128% 31 Dec 2020
Q3 2020 -122% 30 Sep 2020
Q3 2012 39242% 30 Sep 2012
Q2 2012 1776% 30 Jun 2012
Q1 2012 640% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.